All In MedTech

Device Trial Radar · NCT07205367

Validation Study: Extended Wear Performance of the Zio Monitor - SHASTA II

Last checked: Nov 20, 2026Latest source record: Aug 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

150

Actual

Start

Jan 6, 2025

Primary completion

Jul 29, 2025

Study completion Nov 7, 2025

Sponsor

Lead sponsor
iRhythm Technologies, Inc.Public (IRTC)
Sponsor type
Industry
First posted
Oct 3, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated device
Yes
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This trial assesses the wear performance of the Zio monitor, a long-term continuous ambulatory patch ECG monitor, in a representative population by evaluating (1) the wear duration (up to 30 days) of the device, (2) the percentage of analyzable electrocardiographic time and (3) safety by reviewing all adverse events.

Conditions

  • Cardiac Arrhythmia

Interventions

  • Zio MonitorDevice

    The Zio monitor is a long-term continuous ambulatory patch ECG monitor which adheres to the patient's left pectoral region.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean Wear DurationTime frame: 21 - 30 days after baseline
  2. Percent Analyzable TimeTime frame: Up to 30 days (Day 30)
  3. Safety: Skin IrritationTime frame: Up to 30 days (Day 30)

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • iRhythm Technologies - San Francisco, CA

    San Francisco, California

  • iRhythm Technologies - Deerfield, IL

    Deerfield, Illinois

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.